510(k) device
IMMULITE 2000 3gAllergy Specific IgE Vantage
Siemens Healthcare Diagnostics Products, Ltd. · System, Test, Radioallergosorbent (Rast) Immunological (DHB, Class II) · First FDA decision Sep 4, 2026, newest Sep 4, 2026Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "IMMULITE 2000 3gAllergy"
MAUDE reports
25
Brand "IMMULITE 2000 3gAllergy", since 2015
PubMed studies
5
Mentioning "IMMULITE 2000 3gAllergy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing IMMULITE 2000 3gAllergy Specific IgE Vantage
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K260331 · Decided Sep 4, 2026 · 214 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "IMMULITE 2000 3gAllergy", any status and sponsor, newest update first.
No registered device study names "IMMULITE 2000 3gAllergy".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "IMMULITE 2000 3gAllergy", and for the whole product code for context.
This brand
25 reports: 25 malfunction, 0 injury, 0 death
Whole product code DHB
55 reports: 51 malfunction, 4 injury, 0 death
Newest reports for this brand
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
1219913-2026-00037 · Received Feb 12, 2026 · Event dated Jan 9, 2026
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
1219913-2025-00207 · Received Nov 14, 2025 · Event dated Oct 19, 2025
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
1219913-2025-00185 · Received Oct 16, 2025 · Event dated Oct 7, 2025
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "IMMULITE 2000 3gAllergy"[tiab]. The summary above synthesizes these.
- Agreement Between Predictive, Allergen-Specific IgE Values Assessed by ImmunoCAP and IMMULITE 2000 3gAllergyࡊ Assay Systems for Milk and Wheat Allergies.
Al Hawi Y, Nagao M, Furuya K, et al. · Allergy Asthma Immunol Res · 2021
- Comparison of Singleplex Specific IgE Detection Immunoassays: ImmunoCAP Phadia 250 and Immulite 2000 3gAllergy.
Park KH, Lee J, Sim DW, et al. · Ann Lab Med · 2018Comparative Study
- Latex specific IgE: performance characteristics of the IMMULITE 2000 3gAllergy assay compared with skin testing.
Biagini RE, MacKenzie BA, Sammons DL, et al. · Ann Allergy Asthma Immunol · 2006Research Support, N.I.H., Extramural
- In vitro methods for specific IgE detection in cow's milk allergy.
Prates S, Morais-Almeida M, Matos V, et al. · Allergol Immunopathol (Madr) · 2006Comparative Study, Evaluation Study
- Peanut allergy diagnosis in the context of grass pollen sensitization for 125 patients: roles of peanut and cross-reactive carbohydrate determinants specific IgE.
Guilloux L, Morisset M, Codreanu F, et al. · Int Arch Allergy Immunol · 2009Comparative Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code DHB.
- NOVEOS Specific IgE (sIgE)Hycor Biomedical · 510(k) 2026
- Immulite 2000 3GALLERGY Specific Ige Assay KitSiemens Healthcare Diagnostics, Inc. · 510(k) 2012
- ImmunoCAP Specific IgEPhadia AB · 510(k) 2018
- Noveos Immunoanalyzer SystemHycor Biomedical · 510(k) 2022
- ImmunoCAP Allergen d202, Allergen component rDer p 1,House dust mitePhadia AB · 510(k) 2016
- Immulite 2000 3GALLERGY Specific Ige Assay Kit, Model L2KUN6Siemens Medical Solutions Diagnostics · 510(k) 2011
- Immulite 2000 Allergen-Specific IgeDiagnostic Products Corp. · 510(k) 2002
- ImmunoCAP Allergen f433Phadia AB · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.